The energy drink space may have a lesson for the budding cannabis industry, Bank of America Merrill Lynch says.
While there was all kinds of buzz around energy drinks when Red Bull came along in 1997, and several companies got in on the trend, a couple decades later the market has streamlined and just two brands hold the majority of the share.
Like Bulls And Monsters
The market, analyst Christopher Carey wrote in a note, has shaken out to “Bulls and Monsters,” with Red Bull and Monster selling almost nine out of 10 energy drinks in the United States.
The lessons for cannabis, according to Carey: distribution at scale through agreements with established companies looks extremely important for consumer brands in early stages.
While Red Bull was first into the market, Monster made crucial distribution partnerships with big existing beverage companies, including what’s now Anheuser Busch Inbev NV BUD and Coca-Cola Co KO.
Carey noted that while there are about 2,400 cannabis retailers, that’s nothing compared to the roughly 275,000 convenience stores, drug stores and other retailers that established distributors have access to.
Which Companies Will Emerge?
Carey likes Canopy Growth Corp CGC and Cronos Group Inc CRON as the companies most likely to take advantage of the distribution partnership approach.
For Canopy, a partnership with alcoholic beverage company Constellation Brands, Inc. STZ “gives the company a significant competitive advantage when contemplating a national distribution strategy in the US, specifically for CBD products, which are federally legal,” Carey wrote.
Similarly, Cronos has a partnership with legacy cigarette company Altria Group Inc MO, whose products are distributed in more than 230,000 U.S. locations, a key factor in BoA’s recent upgrade of Cronos.
Price Action
Canopy Growth shares were up a little less than 1% on Wednesday at $42.37. Cronos shares were up 1.8% at $16.
Related Links
Bank Of America Double Upgrades Cronos, Says Bear Thesis 'Increasingly Untenable'
Stifel: Canopy Growth Is The 'Best Investable Opportunity' In Cannabis
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.